Alembic Pharmaceuticals Limited Asset Resilience Ratio

Latest as of September 2025: 0.14%

Alembic Pharmaceuticals Limited asset resilience ratio. Alembic Pharmaceuticals Limited (APLLTD) has an Asset Resilience Ratio of 0.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See APLLTD days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs121.50 Million

≈ $1.31 Million USD Cash + Short-term Investments

Total Assets

Rs83.97 Billion

≈ $908.10 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Alembic Pharmaceuticals Limited (2016–2025)

Asset resilience ratio of Alembic Pharmaceuticals Limited from 2016 to 2025. This chart shows how Alembic Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Read Alembic Pharmaceuticals Limited (APLLTD) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Alembic Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Alembic Pharmaceuticals Limited assets under control.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs121.50 Million	0.14%
Total Liquid Assets	Rs121.50 Million	0.14%

Asset Resilience Insights

Limited Liquidity: Alembic Pharmaceuticals Limited maintains only 0.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Alembic Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Alembic Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Alembic Pharmaceuticals Limited Asset Resilience Ratio by Year (2016–2025)

Alembic Pharmaceuticals Limited asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Alembic Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.23%	Rs181.50 Million ≈ $1.96 Million	Rs77.73 Billion ≈ $840.61 Million	-0.19pp
2024-03-31	0.42%	Rs271.30 Million ≈ $2.93 Million	Rs64.46 Billion ≈ $697.07 Million	+0.15pp
2023-03-31	0.27%	Rs166.40 Million ≈ $1.80 Million	Rs61.83 Billion ≈ $668.65 Million	-0.17pp
2022-03-31	0.44%	Rs316.20 Million ≈ $3.42 Million	Rs71.22 Billion ≈ $770.22 Million	-2.34pp
2021-03-31	2.79%	Rs1.87 Billion ≈ $20.22 Million	Rs67.09 Billion ≈ $725.55 Million	-0.34pp
2020-03-31	3.12%	Rs1.87 Billion ≈ $20.22 Million	Rs59.89 Billion ≈ $647.69 Million	+2.93pp
2019-03-31	0.19%	Rs91.00 Million ≈ $984.13K	Rs47.78 Billion ≈ $516.70 Million	-0.12pp
2018-03-31	0.31%	Rs121.80 Million ≈ $1.32 Million	Rs39.41 Billion ≈ $426.21 Million	-1.56pp
2017-03-31	1.87%	Rs503.40 Million ≈ $5.44 Million	Rs26.87 Billion ≈ $290.55 Million	+5.31pp
2016-03-31	-3.44%	Rs-846.16 Million ≈ $-9.15 Million	Rs24.59 Billion ≈ $265.97 Million	--

pp = percentage points

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic

Market Cap

$1.71 Billion

Rs157.80 Billion INR

Market Cap Rank

#6460 Global

#294 in India

Share Price

Rs802.80

Change (1 day)

-0.02%

52-Week Range

Rs646.55 - Rs948.85

All Time High

Rs1247.70